Stockscreener 앱 받기
0.6424
8.53%
0.0505
시간 외 거래:
.67
0.0276
+4.30%
Humacyte Inc 주식(HUMA)의 최신 뉴스
Why BTIG cut its target on Humacyte (HUMA) but kept a bullish view on the bigger opportunity - MSN
Surprises Report: Should I average down on Humacyte Inc stock2026 Catalysts & Comprehensive Market Scan Insights - baoquankhu1.vn
HC Wainwright Issues Positive Forecast for Humacyte Earnings - MarketBeat
Humacyte, Inc. (HUMA) stock sinks as market gains: Here's why - MSN
Humacyte, Inc. (HUMA) Shares Decline Despite Overall Market Rise: The Reason Explained - Bitget
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
HUMA: Benchmark Downgrades Humacyte with Lowered Price Target | - GuruFocus
Benchmark Reaffirms "Speculative Buy" Rating for Humacyte (NASDAQ:HUMA) - MarketBeat
Benchmark Downgrades Humacyte to Speculative Buy From Buy, Adjusts Price Target to $1 From $11 - Moomoo
Earnings Miss: Can Humacyte Inc sustain its profitabilityPortfolio Growth Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
Aug Macro: Does Humacyte Inc Equity Warrant have declining or rising EPS2026 PreEarnings & Weekly Watchlist of Top Performers - baoquankhu1.vn
Piper Sandler Cuts Humacyte (NASDAQ:HUMA) Price Target to $1.00 - MarketBeat
Piper Sandler cuts Humacyte stock price target on weak sales - Investing.com UK
Piper Sandler cuts Humacyte stock price target on weak sales By Investing.com - Investing.com Canada
TD Cowen Has Lowered Expectations for Humacyte (NASDAQ:HUMA) Stock Price - MarketBeat
TD Cowen lowers Humacyte stock price target to $1 on launch concerns - Investing.com
Piper Sandler Maintains Humacyte(HUMA.US) With Hold Rating, Cuts Target Price to $1 - moomoo.com
TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Cuts Target Price to $1 - moomoo.com
Humacyte, Inc. (HUMA) reports Q4 loss, misses revenue estimates - MSN
Why BTIG Cut Its Target on Humacyte (HUMA) but Kept a Bullish View on the Bigger Opportunity - Yahoo Finance
Smart Money: Does Humacyte Inc Equity Warrant have declining or rising EPSPortfolio Update Summary & Stock Market Timing Techniques - baoquankhu1.vn
5 Penny Stocks with Potential to Rise 1000 Percent - Insider Monkey
Humacyte earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Humacyte misses revenue target despite in-line earnings By Investing.com - ca.investing.com
Humacyte 10-K: Revenue $2.04M, EPS $(0.26) - TradingView
Humacyte (NASDAQ: HUMA) details Symvess FDA approval, launch and ATEV pipeline in 10-K - stocktitan.net
Humacyte secures $1.48M Symvess purchase commitment in Saudi Arabia - MSN
Humacyte (NASDAQ:HUMA) Given "Buy" Rating at D. Boral Capital - MarketBeat
Humacyte shares see BTIG price target cut to $3 on lower sales outlook - Investing.com UK
Humacyte shares see BTIG price target cut to $3 on lower sales outlook By Investing.com - Investing.com India
Humacyte (NASDAQ:HUMA) Issues Earnings Results - MarketBeat
BTIG Research Lowers Humacyte (NASDAQ:HUMA) Price Target to $3.00 - MarketBeat
Humacyte Q4 2025 earnings preview - MSN
Humacyte Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Humacyte Q4 2025 revenue misses forecast By Investing.com - Investing.com Australia
Earnings call transcript: Humacyte Q4 2025 revenue misses forecast - Investing.com
HUMA: Symvess adoption grows with strong clinical data, improved pricing, and expanding global reach - TradingView
Humacyte Inc reports results for the quarter ended December 31Earnings Summary - tradingview.com
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Humacyte earnings matched, revenue fell short of estimates - Investing.com
Humacyte misses revenue target despite in-line earnings - Investing.com
Humacyte posts bigger-than-expected Q4 loss - TradingView
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update - marketscreener.com
BRIEF-Humacyte Q4 Basic EPS USD -0.13 - TradingView
HUMA Should I Buy - Intellectia AI
Dip Buying: Can Humacyte Inc deliver consistent EPS growth2026 Big Picture & Growth Focused Investment Plans - baoquankhu1.vn
Humacyte, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener
Humacyte, Inc. (HUMA) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
0.49%
1.47%
자본화:
|
볼륨(24시간):